Last updated: March 5, 2024
Sponsor: University of Ulm
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pregnancy
Treatment
Whey protein-preload OGTT
Clinical Study ID
NCT06170905
78/23
Ages > 18 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Pregnant women between 24+0 and 27+6 (+/- 7 days) weeks of pregnancy aftermenstruation
- BMI before pregnancy: 18 - 29.9 kg/m2
- No known underlying diseases
- Understanding and voluntary signing of a consent form before study-relatedexaminations
Exclusion
Exclusion Criteria:
- Age < 18 years
- Diabetes mellitus type 1 or type 2
- Drug therapy that raises or lowers blood sugar, e.g. steroids, antidiabetics, insulin.
- Endocrine disorders (e.g. hyperthyroidism, polycystic ovary syndrome (PCOS), ...)
- Current depression or other mental illnesses
- Eating disorder
- Regular intake of medication other than vitamins/trace elements during pregnancy
- Estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m²
- C-reactive protein > 10 mg/l
- Transaminase elevation of 2 times the upper norm
- Pre-existing cardiac diseases
- Drug and/or alcohol abuse
- Hb < 12 g/dl
- No consent to be informed about incidentally discovered pathological findings
- Any other (clinical) condition that would endanger participants safety or questionscientific success according to the physicians opinion.
Study Design
Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Whey protein-preload OGTT
Phase:
Study Start date:
February 01, 2024
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
Universityhospital Ulm
Ulm, 89081
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.